EMMA

Emmaus Life Sciences, Inc. EMMA

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode EMMA SQZB ORGS BPTH YECO NRXCF VPRO PHCG HXBM VIBEF
6M -33.33 % -17.32 % -58.33 % -65.79 % -9.89 % 0.00 % -80.00 % 208.00 % -65.12 % 2 252.94 %
YTD 17.65 % -22.83 % -65.12 % -94.35 % -15.52 % 0.00 % -80.00 % 208.00 % -71.88 % -21.57 %
1Y -28.32 % -7.40 % -54.38 % -94.14 % -43.29 % 0.00 % -80.00 % 136.92 % -75.00 % -77.78 %
3Y -97.14 % -97.03 % -96.07 % -99.76 % -95.59 % -92.96 % -80.00 % -39.37 % -91.35 % 347 825 986.96 %
5Y -99.03 % -99.92 % -98.41 % -99.91 % -96.88 % -98.54 % -95.00 % -98.46 % -90.93 % 9 174 211.93 %
10Y -99.95 % -99.83 % -98.16 % -100.00 % -97.74 % -99.24 % -99.89 % -98.46 % -95.20 % 8 315 908.32 %
From the beginning -98.33 % -99.83 % -99.58 % -100.00 % -98.69 % -99.24 % -100.00 % -98.46 % -99.50 % 8 315 908.32 %

Dividend